Patents by Inventor Richard Dixon

Richard Dixon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160303328
    Abstract: Apparatus, e.g. a syringe, for dispensing foam includes means for ensuring that only foam of adequate quality is dispensed. In use, the syringe may be filled from a pressurised canister which generates foam e.g. for therapeutic use in treating varicose veins. An initial quantity of foam dispensed from the canister may be of inadequate quality in which case it should not be used: the syringe includes means to ensure that this initial quantity of foam is diverted to a waste port or to an internal waste chamber e.g. located in the syringe plunger. Foam dispensed after the initial quantity of poor quality foam is stored in the main barrel of the syringe ready for administration to a patient in need of treatment.
    Type: Application
    Filed: June 27, 2016
    Publication date: October 20, 2016
    Inventors: Stuart Brian William KAY, Christopher John HURLSTONE, Julian Richard DIXON, Andrew Gordon POCOCK
  • Publication number: 20160126202
    Abstract: A bridging arrangement includes a first and a second surface defining a gap therebetween. At least one surface of the first and second surface has an anisotropic energy landscape. A plurality of particles defines a path between the first and second surface bridging the gap.
    Type: Application
    Filed: October 12, 2015
    Publication date: May 5, 2016
    Inventors: Thomas J. Brunschwiler, Brian Burg, Richard Dixon, Helge Kristiansen, Piotr Warszynski, Jonas Zuercher
  • Publication number: 20160114106
    Abstract: Apparatus, e.g. a syringe, for dispensing foam includes means for ensuring that only foam of adequate quality is dispensed. In use, the syringe may be filled from a pressurised canister which generates foam e.g. for therapeutic use in treating varicose veins. An initial quantity of foam dispensed from the canister may be of inadequate quality in which case it should not be used: the syringe includes means to ensure that this initial quantity of foam is diverted to a waste port or to an internal waste chamber e.g. located in the syringe plunger. Foam dispensed after the initial quantity of poor quality foam is stored in the main barrel of the syringe ready for administration to a patient in need of treatment.
    Type: Application
    Filed: October 8, 2015
    Publication date: April 28, 2016
    Inventors: Stuart Brian William Kay, Christopher John Hurlstone, Julian Richard Dixon, Andrew Gordon Pocock
  • Patent number: 9309528
    Abstract: The invention provides methods for increasing the level of fermentable carbohydrates in a biofuel crop plant such as alfalfa or switchgrass, by modification of the lignin biosynthetic pathway. Also provided are plants prepared by the methods of the invention. Methods for processing plant tissue and for producing ethanol by utilizing such plants are also provided.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: April 12, 2016
    Assignee: The Samuel Roberts Noble Foundation, Inc.
    Inventors: Richard A. Dixon, Fang Chen, Zengyu Wang
  • Patent number: 9238821
    Abstract: The invention provides methods and compositions for making a dicotyledonous plant that is susceptible to Phymatotrichopsis Root Rot (PRR) more resistant to PRR, by metabolic engineering of the plant's flavonoid and isoflavonoid biosynthetic pathways. Thus, methods for increasing the synthesis and accumulation of medicarpin and/or 7,4?-dihydroxyflavone in plants such as alfalfa are provided.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: January 19, 2016
    Assignee: The Samuel Roberts Noble Foundation, Inc.
    Inventors: Wensheng Li, Srinivasa Rao Uppalapati, Kirankumar S. Mysore, Richard A. Dixon, Lloyd W. Sumner
  • Publication number: 20150354100
    Abstract: Poly-(caffeyl alcohol) (PCFA), also known as C-lignin, is a promising new source of both carbon fibers and pure carbon. PCFA can be used to produce carbon fibers by direct electrospinning, without blending with another polymer to reduce breakage. Analyses have shown that the carbon obtained from PCFA is superior to that obtained from other lignins. The fibers formed from PCFA are smoother, have a narrower diameter distribution, and show very low defects. The PCFA can be obtained by extraction from plant seed coats. Examples of these plants include the vanilla orchid, Vanilla planifolia, and Jatropha curcas. The fibers may be formed through electrospinning, although other methods for forming the fibers, such as extrusion with a carrier polymer, could be used. The fibers may then be carbonized to increase the carbon yield.
    Type: Application
    Filed: June 3, 2015
    Publication date: December 10, 2015
    Inventors: Richard Dixon, Nandika D'Souza, Fang Chen, Mangesh Nar
  • Ink
    Publication number: 20150274994
    Abstract: The invention relates to an ink composition suitable for applications onto solar cells. Specifically, the invention describes several compositions, using nickel/silicon alloys which have been found to be particularly effective contact metallisation of emitter layers. The ratio of nickel to silicon in claimed invention is in the range of 0.1:1 to 1:0.1.
    Type: Application
    Filed: June 11, 2013
    Publication date: October 1, 2015
    Inventors: Richard Dixon, Jose Pedrosa, Kai Man Kerry Yu, Eric Yu
  • Patent number: 9121031
    Abstract: The invention provides methods and compositions for the modulation of proanthocynidin (“PA;” condensed tannin) production in plants. The methods of the invention allow creation of plants having novel phenotypes, such as alterations in levels of PA or in the types of tissues in which PAs are produced. Altered expression of PA in plants may be achieved, for instance without significantly affecting anthocyanin content or overall secondary metabolite profiles. Alternatively, expression of PA in plants may be achieved while also affecting anthocyanin content.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: September 1, 2015
    Assignee: The Samuel Roberts Noble Foundation, Inc.
    Inventors: Jerome A. Verdier, Jian Zhao, Richard A. Dixon, Michael K. Udvardi
  • Publication number: 20150175694
    Abstract: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1? and IL-1? and neutralize IL-1? and IL-1? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1? and IL-1?) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1? and/or IL-1? activity is detrimental.
    Type: Application
    Filed: March 5, 2015
    Publication date: June 25, 2015
    Applicant: ABBVIE INC.
    Inventors: Albert COLLINSON, George Avgerinos, Richard DIXON, Tariq GHAYUR, Zehra KAYMAKCALAN
  • Publication number: 20150166802
    Abstract: A composition for forming a seed layer, the composition comprising: (a.) a first metal fine particle; and (b.) a metallic component selected from a metal oxide fine particle, an organic metal complex, a second metal fine particle, and combinations thereof, wherein the second metal fine particle has a greater affinity for oxygen than the first fine particle. A seed layer as defined, and a coating including a seed layer and the use of this coating. Further, the invention relates to a method of forming a seed layer comprising applying a composition comprising a first metal fine particle, and a metallic component selected from a metal oxide fine particle, an organic metal complex, a second fine metal particle, and combinations thereof, wherein the second metal fine particle has a greater affinity for oxygen than the first metal fine particle to a surface of a substrate, and setting the composition.
    Type: Application
    Filed: July 12, 2013
    Publication date: June 18, 2015
    Applicant: Intrinsiq Materials Ltd.
    Inventors: Richard Dixon, Jose Pedrosa, Dan Johnson, Jorg Schulze, Matthias Dammasch, Dave Baron, Frank Bruning, Robin Taylor
  • Patent number: 9045549
    Abstract: The invention provides methods for modifying lignin, cellulose, xylan, and hemicellulose content in plants, and for achieving ectopic lignification and, for instance, secondary cell wall synthesis in pith cells, by altered regulation of a WRKY transcription factor. Nucleic acid constructs for altered WRKY-TF expression are described. Transgenic plants are provided that comprise modified pith cell walls, and lignin, cellulose, and hemicellulose content. Plants described herein may be used, for example, as improved biofuel feedstock and as highly digestible forage crops.
    Type: Grant
    Filed: November 3, 2011
    Date of Patent: June 2, 2015
    Assignee: The Samuel Roberts Noble Foundation, Inc.
    Inventors: Huanzhong Wang, Fang Chen, Richard A. Dixon
  • Publication number: 20150056383
    Abstract: Method for printing high resolution features on a substrate, the method comprising: depositing a nanoparticle ink, comprising metal/semi-metal nanoparticles and an adhesive compound, having a binder on a substrate; and applying a laser beam, directly on some or all of the deposited nanoparticle ink to define the print feature, wherein the laser beam is configured to remove the nanoparticle coating or binder thereby allowing the adhesive compound to bond to the nanoparticles and the laser beam is further configured to transform the ink to form a metal/semi-metal structure. The remaining uncured structure can be easily washed away using standard developer solutions such as sodium or potassium hydroxide.
    Type: Application
    Filed: August 13, 2012
    Publication date: February 26, 2015
    Applicant: INTRINSIQ MATERIALS LTD.
    Inventors: Jose Pedrosa, Daniel Johnson, Richard Dixon
  • Publication number: 20150048075
    Abstract: Apparatus for curing of nanoparticle material, the apparatus comprising: a receptacle for receiving a substrate upon which a laser of the nanoparticle ink has been placed; and a laser bar diode array comprising a first bar diode laser, the array configured to emit a laser as a continuous wave and to cure the deposited nanoparticle material.
    Type: Application
    Filed: August 16, 2012
    Publication date: February 19, 2015
    Applicant: INTRINSIQ MATERIALS LTD.
    Inventors: Jose Pedrosa, Daniel Johnson, Richard Dixon
  • Publication number: 20140378666
    Abstract: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1? and IL-1? and neutralize IL-1? and IL-1? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1? and IL-1?) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1? and/or IL-1? activity is detrimental.
    Type: Application
    Filed: August 26, 2014
    Publication date: December 25, 2014
    Applicant: ABBVIE INC.
    Inventors: Albert COLLINSON, George Avgerinos, Richard DIXON, Tariq GHAYUR, Zehra KAYMAKCALAN
  • Patent number: 8901371
    Abstract: The invention provides methods for modifying lignin content and composition in plants and achieving associated benefits therefrom involving altered expression of newly discovered MYB4 transcription factors. Nucleic acid constructs for modifying MYB4 transcription factor expression are described. By over-expressing the identified MYB4 transcription factors, for example, an accompanying decrease in lignin content may be achieved. Plants are provided by the invention comprising such modifications, as are methods for their preparation and use.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: December 2, 2014
    Assignee: The Samuel Roberts Noble Foundation, Inc.
    Inventors: Hui Shen, Fang Chen, Richard A. Dixon
  • Patent number: 8809627
    Abstract: The invention provides enzymes that encode O-methyltransferases (OMTs) from Medicago truncatula that allow modification to plant (iso)flavonoid biosynthetic pathways. In certain aspects of the invention, the genes encoding these enzymes are provided. The invention therefore allows the modification of plants for isoflavonoid content. Transgenic plants comprising such enzymes are also provided, as well as methods for improving disease resistance in plants. Methods for producing food and nutraceuticals, and the resulting compositions, are also provided.
    Type: Grant
    Filed: August 16, 2007
    Date of Patent: August 19, 2014
    Assignee: The Samuel Roberts Noble Foundation, Inc.
    Inventors: Bettina E. Broeckling, Chang-Jun Liu, Richard A. Dixon
  • Patent number: 8796509
    Abstract: The invention provides methods for decreasing lignin content and for increasing the level of fermentable carbohydrates in plants by down-regulation of the NST transcription factor. Nucleic acid constructs for down-regulation of NST are described. Transgenic plants are provided that comprise reduced lignin content. Plants described herein may be used, for example, as improved biofuel feedstock and as highly digestible forage crops. Methods for processing plant tissue and for producing ethanol by utilizing such plants are also provided.
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: August 5, 2014
    Assignee: The Samuel Roberts Noble Foundation
    Inventors: Qiao Zhao, Fang Chen, Richard A. Dixon
  • Publication number: 20140155579
    Abstract: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1? and IL-1? and neutralize IL-1? and IL-1? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1? and IL-?) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1? and/or IL-1? activity is detrimental.
    Type: Application
    Filed: May 23, 2013
    Publication date: June 5, 2014
    Applicant: AbbVie Inc.
    Inventors: Albert Collinson, George Avgerinos, Richard Dixon, Tariq Ghayur, Zehra Kaymakcalan
  • Publication number: 20140012305
    Abstract: A cup-like structure for engaging a cervix of a patient includes a rim, and includes a base defining an aperture through which one or more tubular members of a uterine manipulator may extend into the uterus. The cup-like structure is made from one or more of a polyphthalamide (PPA) material and a polyetheretherketone (PEEK) material. A uterine manipulator including a cup-like structure is also disclosed.
    Type: Application
    Filed: July 5, 2012
    Publication date: January 9, 2014
    Applicant: Clinical Innovations, LLC
    Inventors: Jeremy C. Horton, Richard A. Dixon
  • Patent number: 8475766
    Abstract: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for IL-1? and IL-1? and neutralize IL-1? and IL-1? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., IL-1? and IL-1?) and for inhibiting the activity of the antigens, e.g., in a human subject suffering from a disorder in which IL-1? and/or IL-1? activity is detrimental.
    Type: Grant
    Filed: December 11, 2008
    Date of Patent: July 2, 2013
    Assignee: AbbVie Inc.
    Inventors: Albert Collinson, George Avgerinos, Richard Dixon, Tariq Ghayur, Zehra Kaymakcalan